Search research articles
Contact Us
Filters
Showing results (31-40 of 89) with videos related to
Page
of 9
Sort By:
ACS Sensors
|
July 24, 2024
Research Progress of Flexible Piezoresistive Sensors Based on Polymer Porous Materials
Song Han, Sheng Li, Xin Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2013
Assessment of audit methodologies for bias evaluation of tumor progression in oncology clinical trials
Jenny J Zhang, Lijun Zhang, Huanyu Chen, et al.
Therapeutic Innovation & Regulatory Science
|
September 20, 2018
Evaluation of Blinded Independent Central Review of Tumor Progression in Oncology Clinical Trials: A Meta-analysis
Jenny J Zhang, Huanyu Chen, Kun He, et al.
Genes
|
September 29, 2019
Genome-Wide Identification, Characterization and Expression Patterns of the Pectin Methylesterase Inhibitor Genes in <i>Sorghum bicolor</i>
Angyan Ren, Rana Imtiaz Ahmed, Huanyu Chen, et al.
Journal of Nanobiotechnology
|
January 19, 2025
Enhancing hepatocellular carcinoma therapy with DOX-loaded SiO<sub>2</sub> nanoparticles via mTOR-TFEB pathway autophagic flux inhibition
Huanyu Chen, Jun Liu, Zhichao Cao, et al.
Frontiers in Oncology
|
January 22, 2024
Corrigendum: Predictive value of intratumoral-metabolic heterogeneity derived from <sup>18</sup>F-FDG PET/CT in distinguishing microsatellite instability status of colorectal carcinoma
Li Zhang, Yu Liu, Ying Ding, et al.
ACS Omega
|
June 15, 2026
Preclinical Theranostic Study of <sup>68</sup>Ga/<sup>177</sup>Lu/<sup>225</sup>Ac-Labeled Bicyclic Peptides Targeting Nectin‑4 in Lung Cancer
Huanyu Chen, Yuduo Wan, Wanlu Feng, et al.
Frontiers in Oncology
|
May 14, 2023
Predictive value of intratumoral-metabolic heterogeneity derived from <sup>18</sup>F-FDG PET/CT in distinguishing microsatellite instability status of colorectal carcinoma
Li Zhang, Yu Liu, Ying Ding, et al.
Scientific Reports
|
September 28, 2021
In vitro and in vivo comparative study of a novel <sup>68</sup>Ga-labeled PSMA-targeted inhibitor and <sup>68</sup>Ga-PSMA-11
Huanyu Chen, Ping Cai, Yue Feng, et al.
The Oncologist
|
April 12, 2013
Approval summary: Cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil for the first-line treatment of patients with recurrent locoregional or metastatic squamous cell head and neck cancer
Martin H Cohen, Huanyu Chen, Stacy Shord, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 89) with videos related to
Sort By:
Page
of 9
ACS Sensors
|
July 24, 2024
Research Progress of Flexible Piezoresistive Sensors Based on Polymer Porous Materials
Song Han, Sheng Li, Xin Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2013
Assessment of audit methodologies for bias evaluation of tumor progression in oncology clinical trials
Jenny J Zhang, Lijun Zhang, Huanyu Chen, et al.
Therapeutic Innovation & Regulatory Science
|
September 20, 2018
Evaluation of Blinded Independent Central Review of Tumor Progression in Oncology Clinical Trials: A Meta-analysis
Jenny J Zhang, Huanyu Chen, Kun He, et al.
Genes
|
September 29, 2019
Genome-Wide Identification, Characterization and Expression Patterns of the Pectin Methylesterase Inhibitor Genes in <i>Sorghum bicolor</i>
Angyan Ren, Rana Imtiaz Ahmed, Huanyu Chen, et al.
Journal of Nanobiotechnology
|
January 19, 2025
Enhancing hepatocellular carcinoma therapy with DOX-loaded SiO<sub>2</sub> nanoparticles via mTOR-TFEB pathway autophagic flux inhibition
Huanyu Chen, Jun Liu, Zhichao Cao, et al.
Frontiers in Oncology
|
January 22, 2024
Corrigendum: Predictive value of intratumoral-metabolic heterogeneity derived from <sup>18</sup>F-FDG PET/CT in distinguishing microsatellite instability status of colorectal carcinoma
Li Zhang, Yu Liu, Ying Ding, et al.
ACS Omega
|
June 15, 2026
Preclinical Theranostic Study of <sup>68</sup>Ga/<sup>177</sup>Lu/<sup>225</sup>Ac-Labeled Bicyclic Peptides Targeting Nectin‑4 in Lung Cancer
Huanyu Chen, Yuduo Wan, Wanlu Feng, et al.
Frontiers in Oncology
|
May 14, 2023
Predictive value of intratumoral-metabolic heterogeneity derived from <sup>18</sup>F-FDG PET/CT in distinguishing microsatellite instability status of colorectal carcinoma
Li Zhang, Yu Liu, Ying Ding, et al.
Scientific Reports
|
September 28, 2021
In vitro and in vivo comparative study of a novel <sup>68</sup>Ga-labeled PSMA-targeted inhibitor and <sup>68</sup>Ga-PSMA-11
Huanyu Chen, Ping Cai, Yue Feng, et al.
The Oncologist
|
April 12, 2013
Approval summary: Cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil for the first-line treatment of patients with recurrent locoregional or metastatic squamous cell head and neck cancer
Martin H Cohen, Huanyu Chen, Stacy Shord, et al.
Page
of 9